Return to search results
Tazarotene
Tazarotene is a prescription topical gel containing 0.05% tazarotene, a retinoid medication used to treat skin conditions like acne and psoriasis. Manufactured by Cosette Pharmaceuticals, Inc., it's applied to the skin and available in 30g or 100g tubes. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tazarotene is a prescription topical gel containing 0.05% tazarotene, a retinoid medication used to treat skin conditions like acne and psoriasis. Manufactured by Cosette Pharmaceuticals, Inc., it's applied to the skin and available in 30g or 100g tubes. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Tazarotene",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Tazarotene — ANDA 208258 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208258"
}
]
|
| identifier | ANDA208258 |
| issued | 2016-09-16 |
| keyword |
[
"drug-information",
"drug-manufacturers",
"drug-safety",
"health-care",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Tazarotene |
